Inactive Instrument
Abpro Corporation Stock Nasdaq
Stocks
US0008501076
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 1.34M 1.17M 1.09M 1M 1.89M 128M 1.91M 12.84M 5.02M 63.95M 5.05M 4.94M 212M | P/E 2024 |
-2.41x | P/E 2025 | -3.27x |
|---|---|---|---|---|---|
| Enterprise Value | 1.42M 1.24M 1.15M 1.06M 2M 136M 2.03M 13.6M 5.32M 67.76M 5.35M 5.23M 225M | EV / Sales 2024 |
497x | EV / Sales 2025 | - |
| Free-Float |
83.91% | Yield 2024 * |
-
| Yield 2025 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 1.54M | |
| -0.68% | -0.68% | -1.63% | +12.86% | 48.22B | |
| +6.03% | +5.22% | +420.33% | +519.87% | 38.79B | |
| -2.21% | -6.07% | +24.87% | +5.20% | 38.41B | |
| +2.94% | -2.25% | +6.15% | +59.69% | 34.88B | |
| +1.98% | +4.74% | +12.19% | +41.37% | 29.19B | |
| +0.47% | -3.87% | - | - | 16.05B | |
| +0.31% | +0.72% | +32.99% | +122.25% | 16B | |
| +1.59% | +0.44% | +3.43% | +16.80% | 13.53B | |
| -0.98% | -12.98% | -4.82% | -38.09% | 12.22B | |
| Average | +0.94% | +0.01% | +61.69% | +92.49% | 27.48B | |
| Weighted average by Cap. | +1.21% | +1.55% | +78.99% | +112.40% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 183K 159K 148K 136K 257K 17.41M 260K 1.75M 683K 8.7M 687K 672K 28.83M | - |
| Net income | -7.23M -6.28M -5.85M -5.38M -10.17M -688M -10.28M -69.03M -26.98M -344M -27.16M -26.56M -1.14B | -2.89M -2.51M -2.34M -2.15M -4.07M -275M -4.11M -27.6M -10.79M -138M -10.86M -10.62M -456M |
| Net Debt | 478K 415K 387K 355K 672K 45.47M 680K 4.56M 1.78M 22.73M 1.8M 1.76M 75.31M | 80K 69.46K 64.77K 59.5K 113K 7.61M 114K 764K 298K 3.8M 300K 294K 12.6M |
Employees
-
